Literature DB >> 6712858

Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.

P L Malini, E Strocchi, E Ambrosioni.   

Abstract

Effective renal plasma flow and glomerular filtration rate were measured in 22 mild-to-moderate, uncomplicated, essential hypertensive patients during placebo and after 3 months of randomly assigned treatment either with prizidilol (n = 10) or propranolol (n = 12). Measurements were performed at rest and during cycloergometer exercise. For a comparable effect on blood pressure effective renal plasma flow was significantly increased at rest by prizidilol (+9%) and decreased by propranolol (-13.6%); these patterns were maintained during exercise. Glomerular filtration rate was immodified after the treatment with both drugs. It is concluded that prizidilol is an effective hypotensive agent with no deleterious effects on renal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712858      PMCID: PMC1463365          DOI: 10.1111/j.1365-2125.1984.tb02339.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Correlation of renal blood flow determined by the single injection of Hippuran-I 131 with direct measurements of flow.

Authors:  W H Pritchard; R W Eckstein; W J MacIntyre; E Dabaj
Journal:  Am Heart J       Date:  1965-12       Impact factor: 4.749

2.  A simple, reliable method of measuring glomerular filtration rate using single, low dose sodium iothalamate I-131.

Authors:  M L Cohen; F G Smith; R S Mindell; R L Vernier
Journal:  Pediatrics       Date:  1969-03       Impact factor: 7.124

Review 3.  beta-Adrenoceptor antagonists: new drugs and new indications.

Authors:  J Koch-Weser; W H Frishman
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

4.  Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.

Authors:  J G Collier; D W Pitcher
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

5.  Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound.

Authors:  G Leonetti; L Terzoli; C Sala; C Bianchini; A Zanchetti
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

6.  Effect of exercise on renal clearance of atenolol.

Authors:  W D Mason; G Kochak; N Winer; I Cohen
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

7.  Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.

Authors:  R Larsson; B E Karlberg; B Norlander; A Wirsén
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

8.  Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension.

Authors:  D K Falch; A E Odegaard; N Norman
Journal:  Scand J Clin Lab Invest       Date:  1978-04       Impact factor: 1.713

9.  Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).

Authors:  E M Taylor; D Cameron; R J Eden; R Fielden; D A Owen
Journal:  J Cardiovasc Pharmacol       Date:  1981 Mar-Apr       Impact factor: 3.105

10.  Effect of posture and sleep on pharmacokinetics. I. Amoxycillin.

Authors:  M S Roberts; M J Denton
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

View more
  1 in total

Review 1.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.